Search

Your search keyword '"Acquaviva, G."' showing total 4 results
Start Over Author "Acquaviva, G." Publisher elsevier b.v.
4 results on '"Acquaviva, G."'

1. KRAS and TP53 mutations are correlated with lower survival rate in resected pancreatic ductal adenocarcinoma.

Author

Masetti, M., de Biase, D., Lombardi, R., Tumiati, D., Acquaviva, G., di Giacomo, S., Fornelli, A., and Jovine, E.

Subjects
*RATES, *OPERATIVE surgery
Abstract

B Background: b Factors responsible for long-term survival of patients with pancreatic ductal adenocarcinoma (PDAC) underwent surgical procedure are poorly understood. B Conclusion: b Our data strongly support the fact that KRAS and TP53 mutations identify a subset of PCs with worst behaviour. patients with a KRAS/TP53 mutations had a survival rate less than half if compared with that of KRAS/TP53 wild-type subjects. [Extracted from the article]

Published
2019
Full Text
View/download PDF

3. Bu¨schke–Lowenstein tumour in pregnancy

Author

Garozzo, G., Nuciforo, G., Rocchi, C.M., Bonanno, N.M., Sampugnaro, E.G., Piccione, S., Di Stefano, A., Acquaviva, G., Barberi, A.L., and Panella, M.

Subjects
*PREGNANCY, *PAPILLOMAVIRUSES, *CARBON dioxide, *MICROSURGERY, *CESAREAN section, *GENITAL warts, *MEDICAL lasers, *LONGITUDINAL method, *PAPILLOMAVIRUS diseases, *PREGNANCY complications, *TUMORS, *VULVAR tumors
Abstract

During pregnancy a localised human papillomavirus (HPV) lesion may, in rare cases, develop into a Bu¨schke–Lowenstein tumour. The choice of treatment is crucial as standard systemic treatment is teratogenic. We performed laser CO2 microsurgery because it has a low incidence of complications. [Copyright &y& Elsevier]

Published
2003
Full Text
View/download PDF

4. KRAS and TP53 mutations are correlated with lower survival rate in resected pancreatic ductal adenocarcinoma.

Author

Masetti, M., de Biase, D., Lombardi, R., Tumiati, D., Acquaviva, G., di Giacomo, S., Fornelli, A., and Jovine, E.

Subjects
*RATES, *OPERATIVE surgery
Abstract

B Background: b Factors responsible for long-term survival of patients with pancreatic ductal adenocarcinoma (PDAC) underwent surgical procedure are poorly understood. B Conclusion: b Our data strongly support the fact that KRAS and TP53 mutations identify a subset of PCs with worst behaviour. patients with a KRAS/TP53 mutations had a survival rate less than half if compared with that of KRAS/TP53 wild-type subjects. [Extracted from the article]

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results